Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 167

    1.

    Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

    Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Köppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ.

    Diabetes. 2005 Aug;54(8):2320-7.PMID: 16046297 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.

    Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW.

    Nephrol Dial Transplant. 2007 Apr;22(4):1131-5. Epub 2007 Jan 5.PMID: 17205963 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.

    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.

    Diabetes. 2008 Sep;57(9):2547-51.PMID: 18753673 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.

    Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA.

    Diabetes. 2007 Sep;56(9):2410-3. Epub 2007 Jun 29.PMID: 17601991 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.

    McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW.

    Hum Genet. 2009 Aug;126(2):265-75. Epub 2009 Apr 17.PMID: 19373489 [PubMed - indexed for MEDLINE]Related articles

    6.

    L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.

    Sauerhöfer S, Yuan G, Braun GS, Deinzer M, Neumaier M, Gretz N, Floege J, Kriz W, van der Woude F, Moeller MJ.

    Diabetes. 2007 Oct;56(10):2425-32. Epub 2007 Jun 29.PMID: 17601992 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

    Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.PMID: 16270194 [PubMed - indexed for MEDLINE]Related articles

    8.

    Allelic variation in the CNDP1 gene and its lack of association with longevity and coronary heart disease.

    Zschocke J, Nebel A, Wicks K, Peters V, El Mokhtari NE, Krawczak M, van der Woude F, Janssen B, Schreiber S.

    Mech Ageing Dev. 2006 Nov;127(11):817-20. Epub 2006 Sep 11.PMID: 16965804 [PubMed - indexed for MEDLINE]Related articles

    9.

    Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.

    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.

    Diabetes. 2008 Jun 5. [Epub ahead of print]PMID: 18535186 [PubMed - as supplied by publisher]Related articles

    10.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.

    Bakker SJ, Alkhalaf A, Tarnow L, Navis G.

    Diabetes. 2008 Dec;57(12):e16; author reply e17. No abstract available. PMID: 19033401 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.

    Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC.

    Diabetes. 2000 Dec;49(12):2170-7.PMID: 11118022 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

    Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M, Kawai K, Iiizumi T, Imanishi M, Shinosaki T, Yanagimoto T, Ikeda M, Omachi S, Kashiwagi A, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakajima M, Nakamura Y, Maeda S.

    Diabetes. 2005 Apr;54(4):1171-8.PMID: 15793258 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.

    Patel A, Scott WR, Lympany PA, Rippin JD, Gill GV, Barnett AH, Bain SC; Warren 3/UK GoKind Study Group.

    Diabet Med. 2005 Jan;22(1):69-73.PMID: 15606694 [PubMed - indexed for MEDLINE]Related articles

    16.

    TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.

    Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A.

    Nephron Physiol. 2007;106(4):p69-75. Epub 2007 Jul 2.PMID: 17622752 [PubMed - indexed for MEDLINE]Related articles

    17.

    High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.

    Qi W, Chen X, Zhang Y, Holian J, Mreich E, Gilbert RE, Kelly DJ, Pollock CA.

    Nephrol Dial Transplant. 2007 Nov;22(11):3147-53. Epub 2007 Jul 29.PMID: 17664181 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

    Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

    Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy.

    Pueyo ME, Challah M, Gauguier D, Louedec L, Philippe M, Gaertner R, Marre M, Michel JB, Jacob MP.

    Diabetes. 2004 Apr;53(4):1111-8.PMID: 15047629 [PubMed - indexed for MEDLINE]Related articlesFree article